Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Senate Panel Clears Califf; 'Cures' Bill Ahead

This article was originally published in Scrip

Executive Summary

As expected, Robert Califf got a thumbs up on Jan. 12 from the Senate Health, Education, Labor and Pensions (HELP) Committee to take the reins of the FDA.